New Insights Into the Genetics of Spermatogenic Failure: a Review of the Literature
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Non-Syndromic Monogenic Male Infertility
Acta Biomed 2019; Vol. 90, Supplement 10: 62-67 DOI: 10.23750/abm.v90i10-S.8762 © Mattioli 1885 Review Non-syndromic monogenic male infertility Giulia Guerri1, Tiziana Maniscalchi2, Shila Barati2, Gian Maria Busetto3, Francesco Del Giudice3, Ettore De Berardinis3, Rossella Cannarella4, Aldo Eugenio Calogero4, Matteo Bertelli2 1 MAGI’s Lab, Rovereto (TN), Italy; 2 MAGI Euregio, Bolzano, Italy; 3 Department of Urology, University of Rome La Sapien- za, Policlinico Umberto I, Rome, Italy; 4 Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy Summary. Infertility is a widespread clinical problem affecting 8-12% of couples worldwide. Of these, about 30% are diagnosed with idiopathic infertility since no causative factor is found. Overall 40-50% of cases are due to male reproductive defects. Numerical or structural chromosome abnormalities have long been associ- ated with male infertility. Monogenic mutations have only recently been addressed in the pathogenesis of this condition. Mutations of specific genes involved in meiosis, mitosis or spermiohistogenesis result in spermato- genic failure, leading to the following anomalies: insufficient (oligozoospermia) or no (azoospermia) sperm production, limited progressive and/or total sperm motility (asthenozoospermia), altered sperm morphology (teratozoospermia), or combinations thereof. Androgen insensitivity, causing hormonal and sexual impair- ment in males with normal karyotype, also affects male fertility. The genetic causes of non-syndromic mono- genic of male infertility are summarized in this article and a gene panel is proposed. (www.actabiomedica.it) Key words: male infertility, oligozoospermia, azoospermia, asthenozoospermia, teratozoospermia, spermato- genic failure, androgen insensitivity syndrome Introduction development. Genetic causes of male infertility are outlined in Table 1. -
Genetic Counseling and Diagnostic Guidelines for Couples with Infertility And/Or Recurrent Miscarriage
medizinische genetik 2021; 33(1): 3–12 Margot J. Wyrwoll, Sabine Rudnik-Schöneborn, and Frank Tüttelmann* Genetic counseling and diagnostic guidelines for couples with infertility and/or recurrent miscarriage https://doi.org/10.1515/medgen-2021-2051 to both partners prior to undergoing assisted reproduc- Received January 16, 2021; accepted February 11, 2021 tive technology. In couples with recurrent miscarriages, Abstract: Around 10–15 % of all couples are infertile, karyotyping is recommended to detect balanced structural rendering infertility a widespread disease. Male and fe- chromosomal aberrations. male causes contribute equally to infertility, and, de- Keywords: female infertility, male infertility, miscarriages, pending on the defnition, roughly 1 % to 5 % of all genetic counseling, ART couples experience recurrent miscarriages. In German- speaking countries, recommendations for infertile cou- ples and couples with recurrent miscarriages are pub- lished as consensus-based (S2k) Guidelines by the “Ar- Introduction beitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften” (AWMF). This article summarizes the A large proportion of genetic consultation appointments current recommendations with regard to genetic counsel- is attributed to infertile couples and couples with recur- ing and diagnostics. rent miscarriages. Infertility, which is defned by the WHO Prior to genetic counseling, the infertile couple as the inability to achieve a pregnancy after one year of must undergo a gynecological/andrological examination, unprotected intercourse [1], afects 10–15 % of all couples, which includes anamnesis, hormonal profling, physical thus rendering infertility a widespread disease, compara- examination and genital ultrasound. Women should be ex- ble to, e. g., high blood pressure or depression. Histori- amined for the presence of hyperandrogenemia. Men must cally, the female partner has been the focus of diagnos- further undergo a semen analysis. -
Genetics of Male Infertility: Genes Implicated in Non-Obstructive
Genetics of male infertility : genes implicated in non-obstructive azoospermia and severe oligozoospermia Özlem Okutman To cite this version: Özlem Okutman. Genetics of male infertility : genes implicated in non-obstructive azoospermia and severe oligozoospermia. Reproductive Biology. Université de Strasbourg, 2015. English. NNT : 2015STRAJ049. tel-01372898 HAL Id: tel-01372898 https://tel.archives-ouvertes.fr/tel-01372898 Submitted on 27 Sep 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESIS P`VsVJ VR G77 Ö<CVI OKTMAN DV`VJRVR Q``1H1:CC7 SV] VIGV` . IJ P:` 1:C F%C`1CCIVJ Q` .V RV_%1`VIVJ s `Q` .V DV$`VV Q` DQH Q` Q` P.1CQsQ].7 1J SH1VJHVs ``QI .V J10V`s1 7 Q` S `:sGQ%`$ D1sH1]C1JV7 L1`V SH1VJHV :JR HV:C . S]VH1:C1 77 CVCC%C:` B1QCQ$7 :JR DV0VCQ]IVJ GVJV 1Hs Q` I:CV 1J`V` 1C1 7 GVJVs 1I]C1H: VR 1J JQJRQGs `%H 10V :<QQs]V`I1: :JR sV0V`V QC1$Q<QQs]V`I1: T.Vs1s R1`VH Q`7 P`8 S X].:JV IILLE J10V`s1 7 Q` S `:sGQ%`$ R IGBMC5 S `:sGQ%`$5 F`:JHV E6 V`J:C RV]Q` V`s7 P`8 JV:J P1V``V SIFFROI T]1 :C'R;*J`:J -'.`I:JR'1`Q%--V:%5'6:`1-5'7`:JHV P`8 CCXIVJ JIMENE LVs HT]1 :%6 R% CH5 BQ`RV:%65 F`:JHV IJ V`J:C RV]Q` V`s7 P`8 J:IVC CHELL IGBMC5 S `:sGQ%`$5 F`:JHV T.V 1I]Q` :J .1J$ 1s JQ Q s Q] _%Vs 1QJ1J$8 C%`1Qs1 7 .:s 1 s Q1J `V:sQJ `Q` V61s 1J$8 ACGV` E1Js V1J R AH@JQ1CVR$VIVJ s I 11s. -
Should 45,X/46,XY Boys with No Or Mild Anomaly of External Genitalia
3 179 L Dumeige and others 45,X/46,XY phenotypic boys, 179:3 181–190 Clinical Study not so benign? Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up? Laurence Dumeige1,2, Livie Chatelais3, Claire Bouvattier4, Marc De Kerdanet5, Capucine Hyon6, Blandine Esteva7, Dinane Samara-Boustani8, Delphine Zenaty1, Marc Nicolino9, Sabine Baron10, Chantal Metz-Blond11, Catherine Naud-Saudreau12, Clémentine Dupuis13, Juliane Léger1, Jean-Pierre Siffroi6, Bruno Donadille14, Sophie Christin-Maitre14, Jean-Claude Carel1, Regis Coutant3 and Laetitia Martinerie1,2 1Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France, 2INSERM UMR-S1185, Le Kremlin Bicêtre, France, 3Pediatric Department, CHU Angers, Angers, France, 4Pediatric Endocrinology Department, CHU Bicêtre, Centre de Référence des Anomalies du Développement Génital, Assistance-Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France, 5Pediatric Department, CHU Rennes, Rennes, France, 6Genetic Department, 7Pediatric Endocrinology Department, CHU Armand Trousseau, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France, 8Pediatric Endocrinology Department, CHU Necker-Enfants Malades, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France, 9Pediatric -
Genetics of Azoospermia
International Journal of Molecular Sciences Review Genetics of Azoospermia Francesca Cioppi , Viktoria Rosta and Csilla Krausz * Department of Biochemical, Experimental and Clinical Sciences “Mario Serio”, University of Florence, 50139 Florence, Italy; francesca.cioppi@unifi.it (F.C.); viktoria.rosta@unifi.it (V.R.) * Correspondence: csilla.krausz@unifi.it Abstract: Azoospermia affects 1% of men, and it can be due to: (i) hypothalamic-pituitary dysfunction, (ii) primary quantitative spermatogenic disturbances, (iii) urogenital duct obstruction. Known genetic factors contribute to all these categories, and genetic testing is part of the routine diagnostic workup of azoospermic men. The diagnostic yield of genetic tests in azoospermia is different in the different etiological categories, with the highest in Congenital Bilateral Absence of Vas Deferens (90%) and the lowest in Non-Obstructive Azoospermia (NOA) due to primary testicular failure (~30%). Whole- Exome Sequencing allowed the discovery of an increasing number of monogenic defects of NOA with a current list of 38 candidate genes. These genes are of potential clinical relevance for future gene panel-based screening. We classified these genes according to the associated-testicular histology underlying the NOA phenotype. The validation and the discovery of novel NOA genes will radically improve patient management. Interestingly, approximately 37% of candidate genes are shared in human male and female gonadal failure, implying that genetic counselling should be extended also to female family members of NOA patients. Keywords: azoospermia; infertility; genetics; exome; NGS; NOA; Klinefelter syndrome; Y chromosome microdeletions; CBAVD; congenital hypogonadotropic hypogonadism Citation: Cioppi, F.; Rosta, V.; Krausz, C. Genetics of Azoospermia. 1. Introduction Int. J. Mol. Sci. -
Cellular and Molecular Aspects of the Response of the Testis to Nutrition In
Cellular and molecular aspects of the response of the testis to nutrition in sexually mature sheep Yongjuan Guan 21004548 This thesis is presented for the degree of Doctor of Philosophy of The University of Western Australia School of Animal Biology Institute of Agriculture March 2015 Declaration Declaration The work presented in this thesis is original work of the author, and none of the material in this thesis has been submitted either in full, or part, for a degree at this university or any other universities or institutions before. The experimental designs and manuscript preparation were carried out by myself after discussion with my supervisors Prof Graeme Martin, A/Prof Irek Malecki and Dr Penny Hawken. Yongjuan Guan March 2015 1 Contents Contents Summary ....................................................................................................................................... 4 Acknowledgements ....................................................................................................................... 8 Publications ................................................................................................................................. 10 Chapter 1: General Introduction ................................................................................................. 12 Chapter 2: Literature Review ...................................................................................................... 16 2.1 Male reproduction ............................................................................................................ -
Integrating Clinical and Genetic Approaches in the Diagnosis of 46,XY Disorders of Sex Development
ID: 18-0472 7 12 Z Kolesinska et al. Diagnostic approach of 46,XY 7:12 1480–1490 DSD RESEARCH Integrating clinical and genetic approaches in the diagnosis of 46,XY disorders of sex development Zofia Kolesinska1, James Acierno Jr2, S Faisal Ahmed3, Cheng Xu2, Karina Kapczuk4, Anna Skorczyk-Werner5, Hanna Mikos1, Aleksandra Rojek1, Andreas Massouras6, Maciej R Krawczynski5, Nelly Pitteloud2 and Marek Niedziela1 1Department of Pediatric Endocrinology and Rheumatology, Poznan University of Medical Sciences, Poznan, Poland 2Endocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland 3Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK 4Division of Gynecology, Department of Perinatology and Gynecology, Poznan University of Medical Sciences, Poznan, Poland 5Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland 6Saphetor, SA, Lausanne, Switzerland Correspondence should be addressed to M Niedziela: [email protected] Abstract 46,XY differences and/or disorders of sex development (DSD) are clinically and Key Words genetically heterogeneous conditions. Although complete androgen insensitivity f array-comparative syndrome has a strong genotype–phenotype correlation, the other types of 46,XY DSD genomic hybridization are less well defined, and thus, the precise diagnosis is challenging. This study focused f differences and/or disorders of sex on comparing the relationship between clinical assessment and genetic findings in development a cohort of well-phenotyped patients with 46,XY DSD. The study was an analysis of f massive parallel/next clinical investigations followed by genetic testing performed on 35 patients presenting generation sequencing to a single center. The clinical assessment included external masculinization score f oligogenicity (EMS), endocrine profiling and radiological evaluation. -
Major Spliceosome Defects Cause Male Infertility and Are Associated with Nonobstructive Azoospermia in Humans
Major spliceosome defects cause male infertility and are associated with nonobstructive azoospermia in humans Hao Wua,b,1, Liwei Sunc,d,1, Yang Wena,e,1, Yujuan Liua,b, Jun Yua,b, Feiyu Maoc,f, Ya Wanga,b, Chao Tongg, Xuejiang Guoa,b, Zhibin Hua,e, Jiahao Shaa,b, Mingxi Liua,b,2, and Laixin Xiac,2 aState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, People’s Republic of China; bDepartment of Histology and Embryology, Nanjing Medical University, Nanjing 210029, People’s Republic of China; cKey Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China; dState Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, People’s Republic of China; eDepartment of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, People’s Republic of China; fState Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, People’s Republic of China; and gLife Sciences Institute and Innovation Center for Cell Biology, Zhejiang University, Hangzhou 310058, People’s Republic of China Edited by Margaret T. Fuller, Stanford University School of Medicine, Stanford, CA, and approved February 19, 2016 (received for review July 12, 2015) Processing of pre-mRNA into mRNA is an important regulatory Drosophila (9). Therefore, Drosophila provides a simple system mechanism in eukaryotes that is mediated by the spliceosome, a for investigating the complex genetic basis and related mo- huge and dynamic ribonucleoprotein complex. -
Genetic Evaluation of Patients with Non-Syndromic Male Infertility
Journal of Assisted Reproduction and Genetics https://doi.org/10.1007/s10815-018-1301-7 REVIEW Genetic evaluation of patients with non-syndromic male infertility Ozlem Okutman1,2 & Maroua Ben Rhouma1 & Moncef Benkhalifa3 & Jean Muller4,5 & Stéphane Viville1,2 Received: 24 July 2018 /Accepted: 28 August 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Purpose This review provides an update on the genetics of male infertility with emphasis on the current state of research, the genetic disorders that can lead to non-syndromic male infertility, and the genetic tests available for patients. Methods A comprehensive review of the scientific literature referenced in PubMed was conducted using keywords related to male infertility and genetics. The search included articles with English abstracts appearing online after 2000. Results Mutations in 31 distinct genes have been identified as a cause of non-syndromic human male infertility, and the number is increasing constantly. Screening gene panels by high-throughput sequencing can be offered to patients in order to identify genes involved in various forms of human non-syndromic infertility. We propose a workflow for genetic tests which takes into account semen alterations. Conclusions The identification and characterization of the genetic basis of male infertility have broad implications not only for understanding the cause of infertility but also in determining the prognosis, selection of treatment options, and management of couples. Genetic diagnosis is essential for the success of ART techniques and for preserving future fertility as well as the prognosis for testicular sperm extraction (TESE) and adopted therapeutics. Keywords Male infertility . Non-syndromic . -
Single-Cell RNA Sequencing of Human, Macaque, and Mouse Testes Uncovers Conserved and Divergent Features of Mammalian Spermatogenesis
bioRxiv preprint doi: https://doi.org/10.1101/2020.03.17.994509; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Single-cell RNA sequencing of human, macaque, and mouse testes uncovers conserved and divergent features of mammalian spermatogenesis Adrienne Niederriter Shami1,7, Xianing Zheng1,7, Sarah K. Munyoki2,7, Qianyi Ma1, Gabriel L. Manske3, Christopher D. Green1, Meena Sukhwani2, , Kyle E. Orwig2*, Jun Z. Li1,4*, Saher Sue Hammoud1,3,5,6,8* 1Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA 2 Department of Obstetrics, Gynecology and Reproductive Sciences, Integrative Systems Biology Graduate Program, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA. 3 Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, USA 4 Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA 5 Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA 6Department of Urology, University of Michigan, Ann Arbor, MI, USA 7 These authors contributed equally 8 Lead Contact * Correspondence: [email protected] (K.E.O.), [email protected] (J.Z.L.), [email protected] (S.S.H.) bioRxiv preprint doi: https://doi.org/10.1101/2020.03.17.994509; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary Spermatogenesis is a highly regulated process that produces sperm to transmit genetic information to the next generation. -
Novel Mutations Segregating with Complete Androgen Insensitivity Syndrome and Their Molecular Characteristics
International Journal of Molecular Sciences Article Novel Mutations Segregating with Complete Androgen Insensitivity Syndrome and Their Molecular Characteristics Agnieszka Malcher 1, Piotr Jedrzejczak 2, Tomasz Stokowy 3 , Soroosh Monem 1, Karolina Nowicka-Bauer 1, Agnieszka Zimna 1, Adam Czyzyk 4, Marzena Maciejewska-Jeske 4, Blazej Meczekalski 4, Katarzyna Bednarek-Rajewska 5, Aldona Wozniak 5, Natalia Rozwadowska 1 and Maciej Kurpisz 1,* 1 Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland; [email protected] (A.M.); [email protected] (S.M.); [email protected] (K.N.-B.); [email protected] (A.Z.); [email protected] (N.R.) 2 Division of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics and Gynecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland; [email protected] 3 Department of Clinical Science, University of Bergen, 5020 Bergen, Norway; [email protected] 4 Department of Gynecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland; [email protected] (A.C.); [email protected] (M.M.-J.); [email protected] (B.M.) 5 Department of Clinical Pathology, Poznan University of Medical Sciences, 60-355 Poznan, Poland; [email protected] (K.B.-R.); [email protected] (A.W.) * Correspondence: [email protected]; Tel.: +48-61-6579-202 Received: 11 October 2019; Accepted: 29 October 2019; Published: 30 October 2019 Abstract: We analyzed three cases of Complete Androgen Insensitivity Syndrome (CAIS) and report three hitherto undisclosed causes of the disease. RNA-Seq, Real-timePCR, Western immunoblotting, and immunohistochemistry were performed with the aim of characterizing the disease-causing variants. -
Maturitas Long-Term Health Issues of Women with XY Karyotype
Maturitas 65 (2010) 172–178 Contents lists available at ScienceDirect Maturitas journal homepage: www.elsevier.com/locate/maturitas Review Long-term health issues of women with XY karyotype Marta Berra a,b,∗, Lih-Mei Liao a,b, Sarah M. Creighton a,b, Gerard S. Conway a,b a Department of Adolescent Gynaecology and Reproductive Endocrinology, University College London Hospitals, UK b Elizabeth Garrett Anderson UCL Institute for Women’s Health, University College London, UK article info abstract Article history: 46XY women is a label that gathers together a number of different conditions for which the natural history Received 27 November 2009 in to adult life is still only partially known. A common feature is the difficulty that many women encounter Accepted 3 December 2009 when approaching clinicians. In this review we assemble medical, surgical and psychological literature pertaining adult 46XY women together with our experience gained from an adult DSD clinic. There is increasing awareness for the need for multidisciplinary team involving endocrinologist, gynaecology, Keywords: nurse specialist and particularly clinical psychologists. Disorder of sex development Management of adult women with a 46XY karyotype includes several aspects: revising the diagnosis Intersex Gonadectomy in those with previously incomplete workup; exploring issues of disclosure of details of the diagnosis. Psychological care Surgery needs to be discussed when the gonads are still in situ and when partial virilisation of genitalia have occurred. To maintain secondary sexual characteristics, for general well being and for bone health, most women require sex steroid replacement continuously until the approximately age of 50 and it is important that the treatment is tailored on individual basis.